Actively Recruiting
Hyperinflation Respiratory Therapies in Cardiac Surgery Patients
Led by University of Texas Southwestern Medical Center · Updated on 2025-11-04
324
Participants Needed
1
Research Sites
445 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this prospective randomized clinical trial is to evaluate three different types of hyperinflation respiratory therapies, Intermittent Positive Pressure Breathing (IPPB), Intermittent positive end expiratory pressure (EzPAP), Metaneb. Investigators will examine which hyperinflation therapy provides better lung expansion and may improve lung recovery after surgery.
CONDITIONS
Official Title
Hyperinflation Respiratory Therapies in Cardiac Surgery Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years and older
- Admitted to Cardiovascular ICU after coronary artery bypass grafting, isolated valve repair/replacement, or both
- Cardiac surgery performed via median sternotomy
You will not qualify if you...
- Body mass index (BMI) greater than 40
- Refusal to provide consent
- Prior or current lung transplant patients
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UT Southwestern Clements University Hospital
Dallas, Texas, United States, 75390
Actively Recruiting
Research Team
J
Jaffer Odeh, MD
CONTACT
E
Emily Melikman, RN
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here